Literature DB >> 21531895

Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus.

Michael J Molloy1, Weijun Zhang, Edward J Usherwood.   

Abstract

There is an urgent need to develop novel therapies for controlling chronic virus infections in immunocompromised patients. Disease associated with persistent γ-herpesvirus infection (EBV, human herpesvirus 8) is a significant problem in AIDS patients and transplant recipients, and clinical management of these conditions is difficult. Immune surveillance failure followed by γ-herpesvirus recrudescence can be modeled using murine γ-herpesvirus (MHV)-68 in mice lacking CD4(+) T cells. In contrast with other chronic infections, no obvious defect in the functional capacity of the viral-specific CD8(+) T cell response was detected. We show in this article that adoptive transfer of MHV-68-specific CD8(+) T cells was ineffective at reducing the viral burden. Together, these indicate the potential presence of T cell extrinsic suppressive factors. Indeed, CD4-depleted mice infected with MHV-68 express increased levels of IL-10, a cytokine capable of suppressing the function of both APCs and T cells. CD4-depleted mice developed a population of CD8(+) T cells capable of producing IL-10 that suppressed viral control. Although exhibiting cell surface markers indicative of activation, the IL-10-producing cells expressed increased levels of programmed death-1 but were not enriched in the MHV-68-specific compartment, nor were they uniformly CD44(hi). Therapeutic administration of an IL-10R blocking Ab enhanced control of the recrudescent virus. These data implicate IL-10 as a promising target for the restoration of immune surveillance against chronic γ-herpesvirus infection in immunosuppressed individuals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531895      PMCID: PMC3854932          DOI: 10.4049/jimmunol.1003812

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  Helping the CD8(+) T-cell response.

Authors:  Michael J Bevan
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 3.  IL-10 and the resolution of infections.

Authors:  C M Filippi; M G von Herrath
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

4.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 5.  Derangement of immune responses by myeloid suppressor cells.

Authors:  Paolo Serafini; Carmela De Santo; Ilaria Marigo; Sara Cingarlini; Luigi Dolcetti; Giovanna Gallina; Paola Zanovello; Vincenzo Bronte
Journal:  Cancer Immunol Immunother       Date:  2003-10-30       Impact factor: 6.968

Review 6.  Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.

Authors:  G Verucchi; L Calza; R Manfredi; F Chiodo
Journal:  Infection       Date:  2004-02       Impact factor: 3.553

7.  Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.

Authors:  Daniele Accapezzato; Vittorio Francavilla; Marino Paroli; Marco Casciaro; Lucia Valeria Chircu; Agostino Cividini; Sergio Abrignani; Mario U Mondelli; Vincenzo Barnaba
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes.

Authors:  Lorenzo Cosmi; Francesco Liotta; Elena Lazzeri; Michela Francalanci; Roberta Angeli; Benedetta Mazzinghi; Veronica Santarlasci; Roberto Manetti; Vittorio Vanini; Paola Romagnani; Enrico Maggi; Sergio Romagnani; Francesco Annunziato
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

9.  Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.

Authors:  Susanne Knapp; Branwen J W Hennig; Angela J Frodsham; Lyna Zhang; Simon Hellier; Mark Wright; Rob Goldin; Adrian V S Hill; Howard C Thomas; Mark R Thursz
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

10.  Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.

Authors:  Seiji Miyazoe; Keisuke Hamasaki; Keisuke Nakata; Yuji Kajiya; Kayo Kitajima; Kazuhiko Nakao; Manabu Daikoku; Hiroshi Yatsuhashi; Michiaki Koga; Michitami Yano; Katsumi Eguchi
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  35 in total

1.  Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Authors:  Zhuting Hu; Marcia A Blackman; Kenneth M Kaye; Edward J Usherwood
Journal:  J Immunol       Date:  2015-02-06       Impact factor: 5.422

2.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth.

Authors:  Xiaozhan Liang; Rebecca L Crepeau; Weijun Zhang; Samuel H Speck; Edward J Usherwood
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

4.  Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.

Authors:  Ryan N Jennings; Jason M Grayson; Erik S Barton
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

5.  A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.

Authors:  Bénédicte Machiels; Laurent Gillet; Mickaël Dourcy; Céline Maquet; Lorène Dams; Gautier Gilliaux; Justine Javaux; Daniel Desmecht; Matthias Mack; Benjamin G Dewals
Journal:  Mucosal Immunol       Date:  2020-05-18       Impact factor: 7.313

Review 6.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

7.  Promotion of a subdominant CD8 T cell response during murine gammaherpesvirus 68 infection in the absence of CD4 T cell help.

Authors:  Michael L Freeman; Alan D Roberts; Claire E Burkum; David L Woodland; Marcia A Blackman
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

Review 8.  A naturally occurring CD8(+)CD122(+) T-cell subset as a memory-like Treg family.

Authors:  Shanshan Li; Qingfeng Xie; Yuqun Zeng; Chuan Zou; Xusheng Liu; Shouhai Wu; Haixia Deng; Yang Xu; Xian C Li; Zhenhua Dai
Journal:  Cell Mol Immunol       Date:  2014-05-05       Impact factor: 11.530

9.  IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response.

Authors:  Junjie Zhang; Hao Feng; Jun Zhao; Emily R Feldman; Si-Yi Chen; Weiming Yuan; Canhua Huang; Omid Akbari; Scott A Tibbetts; Pinghui Feng
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

10.  CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.

Authors:  Sharvan Sehrawat; Oktay Kirak; Paul-Albert Koenig; Marisa K Isaacson; Sofia Marques; Gunes Bozkurt; J Pedro Simas; Rudolph Jaenisch; Hidde L Ploegh
Journal:  Cell Rep       Date:  2012-04-26       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.